[HTML][HTML] [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on …

JM Carrascosa, L Puig, IB Romero… - Actas dermo …, 2022 - Elsevier
Background and objectives Since its inception, the Psoriasis Group (GPs) of the Spanish
Academy of Dermatology and Venereology (AEDV) has worked to continuously update …

[HTML][HTML] Hepatotoxicity induced by biological agents: clinical features and current controversies

N Hernandez, F Bessone - Journal of Clinical and Translational …, 2022 - ncbi.nlm.nih.gov
Novel biological agents including cytokines and recombinant fusion proteins are
increasingly prescribed for cancer, rheumatologic, autoimmune, and inflammatory diseases …

[HTML][HTML] Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento …

JM Carrascosa, L Puig, IB Romero… - Actas Dermo …, 2022 - Elsevier
Justificación y objetivos El desarrollo del actual arsenal terapéutico fundamentado en las
terapias biológicas, la experiencia acumulada en ensayos clínicos y en práctica clínica real …

Psoriatic arthritis: the influence of co-morbidities on drug choice

S Patel, A Kumthekar - Rheumatology and Therapy, 2022 - Springer
Psoriatic arthritis (PsA) is associated with a higher burden of co-morbidities such as obesity,
cardiovascular disease, non-alcoholic fatty liver disease, inflammatory eye disease …

Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities

LL Mateu-Arrom, LL Puig - Expert Review of Clinical Pharmacology, 2024 - Taylor & Francis
Introduction Psoriasis is a chronic inflammatory skin disease often associated with several
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …

The Saudi consensus recommendations for the management of psoriatic arthritis (2023)

IA Al-Homood, N Al Ghanim, MIA Fatani… - Clinical …, 2024 - Springer
Psoriatic arthritis (PsA) is a complex inflammatory disease characterized by musculoskeletal
and non-musculoskeletal manifestations. It is a distinct disease entity at the interface …

Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?

S Anvari, K Tsoi - Journal of Clinical Medicine, 2024 - mdpi.com
Hepatitis B virus (HBV) reactivation in the setting of immunosuppressive therapy is an
increasingly recognized and preventable cause of elevated liver enzymes and clinical …

Infections in the era of immunobiologicals

R Romiti, ALS Hirayama, AM Porro… - Anais Brasileiros de …, 2024 - SciELO Brasil
Immunobiologicals represent an innovative therapeutic option in dermatology. They are
indicated in severe and refractory cases of different diseases when there is contraindication …

《 脊柱关节炎靶向药物治疗专家共识》 要点解读

杨晓曦, 田新平, 李梦涛, 冷晓梅, 赵岩, 曾小峰 - 协和医学杂志, 2024 - xhyxzz.pumch.cn
脊柱关节炎(spondyloarthritis, SpA) 是一组以中轴骨和/或外周关节受累为主的慢性炎症性,
致残性风湿免疫病, 严重影响患者的身体功能和生活质量. 随着靶向药物的临床应用越来越多 …

免疫检查点抑制剂抗肿瘤治疗与HBV 再激活的关系.

陈顺, 解有成, 王俊科, 赵宝银… - Journal of Clinical …, 2023 - search.ebscohost.com
近年来, 免疫检查点抑制剂(ICI) 单药和联合治疗在从实体瘤到淋巴瘤等多种恶性肿瘤中取得了
广泛的疗效, 并且成为了多种癌症的标准化和系统化治疗模式. 然而, 在HBV …